Organic compounds (total related compounds in database, current show from 141 to 150) |
|
|
3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide |
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
CH
3
HO
OH
OH
OH
CH
3
HO
H
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
O
CH
3
NH
O
OH
O
CH
3
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-amine |
Depiction based on curated SMILES
NH
2
N
B
CH
3
CH
3
CH
3
H
3
C
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-[3-methyl-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3,4-dihydro-2H-isoquinolin-1-one |
Depiction based on curated SMILES
HO
OH
OH
OH
O
O
CH
3
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2H-isoquinolin-1-one |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-3,4-dihydro-2H-isoquinolin-1-one |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Norharmane |
Depiction based on curated SMILES
N
H
N
|
Escherichia Pseudomonas |
Biofilm Biofilm |
Preclinical (in vivo) Preclinical (in vitro) |
Lee JH, et al. 2017. Phytomedicine
|
|
Methyl 3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]sulfanylphenyl]benzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
S
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Methyl 3-[4-[[(2S,3S,4S,5S,6R)-3,4,5-trihyd roxy-6-(hyd roxymethyl)tetrahydropyran-2-yl]amino]phenyl]benzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
N
H
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
| | |
|
NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.
 |
Back to top |
|